The PV-IN proteomic module was less abundant in AD cases, compared to both asymptomatic AD and control patients, and this decrease in M33 was also correlated with AD neuropathological features (Aβ pathology, neurofibrillary tangles), severity of cognitive dysfunction, and rate of cognitive decline although independent of APOE genetic risk. The gene discussed is APOE; the disease is Alzheimer disease.